New soft mist inhaler is effective and easy to use in patients with asthma and COPD

P. Kardos, W. Golisch, K. Wolf (Frankfurt, Ingelheim, Germany)

Source: Annual Congress 2005 - Asthma and COPD: medication and management in primary care
Session: Asthma and COPD: medication and management in primary care
Session type: Thematic Poster Session
Number: 2213
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Kardos, W. Golisch, K. Wolf (Frankfurt, Ingelheim, Germany). New soft mist inhaler is effective and easy to use in patients with asthma and COPD. Eur Respir J 2005; 26: Suppl. 49, 2213

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Preference for novel soft mist inhaler over pMDI in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 88s
Year: 2004

Description of the UK’s asthma and COPD inhaler use
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Inhaler treatment options in COPD
Source: Eur Respir Rev 2005; 14: 102-108
Year: 2005



Long-term preference and ease of use of a novel dry powder inhaler with budesonide in comparison to a conventional inhaler in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 121s
Year: 2001

A digital inhaler uncovering patterns of SABA use in asthma and COPD
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020


Inhaler choice in primary practice
Source: Eur Respir Rev 2005; 14: 117-122
Year: 2005



How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Broncho dilator response to salbutamol delivered by metered dose inhaler with spacer versus dry powder inhaler in acute asthma in children
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

Investigating inhaler technique in patients with COPD using different aids
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019

The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012


Handling and patient preference of dry powder inhalers for asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006

Preferences for current inhaler devices in patients with asthma
Source: International Congress 2018 – Asthma and drugs
Year: 2018


Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

A novel NEXT DPI® dry powder inhaler and its use in asthmatic and COPD population
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011

How does the Novolizer fit into the choice of inhaler?
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005

COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018



Utility of inhaled corticosteroids (fluticasone/formoterol) by pressurized metered-dose inhaler for the early management of acute exacerbations of asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010

Effect of switching from salmeterol/fluticasone dry powder inhaler to formoterol/fluticasone pressurized metered-dose inhaler in elderly asthma patients
Source: International Congress 2016 – Asthma management
Year: 2016


The effect of inhaler switching on asthma and COPD patients
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018